Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Immunotherapy, Personalized Medicine to Highlight Winter Hematology Meeting

February 20th 2015

Oncologists, hematologists, and other experts on hematologic malignancies will convene for the 19th Annual International Congress on Hematologic Malignancies, from February 20-21 in Miami, Florida, to provide insight into recent developments in the treatment of the diseases.

Slamon's Tenacity Advances the Field of Breast Cancer Research

February 19th 2015

Dennis J. Slamon, MD, PhD, has had an immeasurable impact on the treatment of women with breast cancer by developing trastuzumab (Herceptin) and helping to launch the era of targeted therapies. He was honored in the Breast Cancer category with a 2014 Giants of Cancer Careâ„¢ award, a program that the Intellisphere® Oncology Specialty Group launched to honor leaders in the field.

The Time Is Right for True Precision Medicine in Oncology

February 13th 2015

We hear the terms individualized, personalized, and precision medicine often used interchangeably. Everyone would agree, however, that the "one-size-fits-all blockbuster drugs/approach" is over.

Radium-223 for Treatment of Prostate Cancer

February 13th 2015

Antiandrogen Resistance With AR-V7 in CRPC

February 13th 2015

Enzalutamide Offers Second Option in Pre-Chemo CRPC

February 13th 2015

Pre-Chemotherapy Abiraterone Acetate in CRPC

February 13th 2015

Integrating CHAARTED Findings Into Prostate Cancer Care

February 13th 2015

CHAARTED Trial Changes Practice in Prostate Cancer

February 13th 2015

ADT in Prostate Cancer: Agonists Versus Antagonists

February 13th 2015

Integrating Molecular Testing Into Urology Practices

February 13th 2015

Biomarkers for Aiding Risk Stratification and Treatment Decisions

February 13th 2015

Follow-up Biomarker Testing in Prostate Cancer

February 13th 2015

Strategies for Using Biomarkers in Prostate Cancer

February 13th 2015

Dr. Chachoua on Afatinib for Exon 19 Mutation in Lung Cancer

February 11th 2015

Abraham Chachoua, MD, associate director of cancer services at NYU Langone Medical Center, talks about targeted treatment for mutations in non-small cell lung cancer and adenocarcinoma.

President Details $215 Million 'Precision Medicine Initiative'

January 31st 2015

The 'precision medicine initiative' proposed by President Barack Obama will require an initial investment of $215 million and consent from 1 million volunteers, with the goal of discovering potential cures for patients with cancer.

Final Thoughts on Improving Outcomes in CRC

January 30th 2015

Impact of Vitamin D on Colorectal Cancer Outcomes

January 30th 2015

Molecular Profiling in Colorectal Cancer

January 30th 2015

Measuring Therapeutic Response in Colon Cancer

January 30th 2015